Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
NCT ID: NCT01791673
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2012-11-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
NCT01338467
Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)
NCT01592955
Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients
NCT02789293
Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).
NCT01908985
Cyclophotocoagulation in Primary Open Angle Glaucoma
NCT04430296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound Glaucoma treatment
Cyclocoagulation using High Intensity Focused Ultrasound (HIFU)
Ultrasound glaucoma treatment
Ultrasound glaucoma treatment with EYEOP1 device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound glaucoma treatment
Ultrasound glaucoma treatment with EYEOP1 device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IOP \> 21 mm Hg on glaucoma medications, and indicated for filtering glaucoma surgery
* Patient must be aged 18 years and more
* No previous cyclophotocoagulation procedure in the eye
* No previous laser treatment in the eye during the 3 months before HIFU procedure
Exclusion Criteria
* History of ocular or retrobulbar tumor
* retinal detachment, choroidal hemorrhage or detachment
* Ocular infectious diseasee within 14 days before HIFU procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EyeTechCare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe DENIS, MD
Role: PRINCIPAL_INVESTIGATOR
Croix Rousse University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Dijon, , France
Michallon University Hospital
Grenoble, , France
Huriez University Hospital
Lille, , France
Croix Rousse University Hospital
Lyon, , France
HIA - Val de Grace Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EYEMUST-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.